Press release
GMP Storage Market is expected to witness a significant volume CAGR of approximately 5.6% through 2032
Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/33113
A historic CAGR of 4.4% was seen in the last nine years, from 2012 to 2021, on the global GMP storage market. The development of large molecule biological products that need to be stored chilled or frozen has been spurred by the current emphasis on vaccine manufacture. The global market is positively impacted by these new items, but temperature-controlled GMP storage is essential.
The cost of building and maintaining temperature-controlled GMP storage facilities is the first consideration. In addition to refrigeration equipment, such facilities require significant security, building management/temperature monitoring, inventory management, and backup power systems. For the upkeep and operation of the equipment as well as regulatory compliance, they also require qualified personnel.
Get up to 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/33113
Companies
ThermoGenesis Holdings, Inc.
ThermoFisher Scientific Inc.
BioLife Solutions, Inc.
Danaher(Cytiva)
MEDIPOST
REMI GROUP
Eurofins Scientific
Eppendorf
Intertek Group Plc
Arctiko
Bioline Technologies
Hindustan Apparatus Mfg. Co.
P L Tandon & Co.
Stericox India Private Limited
SY-LAB Geräte GmbH
BioConvergence LLC d/b/a Singota Solutions
PHC Holdings Corporation
Pace Life Sciences
Haier Biomedical
Helmer Scientific Inc.
Competitive Landscape
To strengthen their product lines around the globe, leading manufacturers are developing technologically-advanced products. Similarly, several major competitors in the GMP storage industry have engaged in consolidation activities such as mergers & acquisitions. Another significant approach noticed in the industry is the expansion of corporate collaborations to boost their GMP storage services.
BioLife Solutions, Inc. acquired Global Cooling, Inc. in May 2021, which has a portfolio of freezers ranging in size from portable units to stationary upright freezers to suit a wide range of applications.
BioLife Solutions debuted a new high-capacity, controlled-rate freezer line in April 2021, with the first shipment going to a leading cell treatment provider.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/33113
Key Segments Covered in GMP Storage Industry Research
GMP Storage Market by Product & Service: GMP Storage Products : Refrigerators and Freezers, Cryogenic Storage, GMP Storage Services
GMP Storage Market by Application: Cell & Gene Therapy, Cell Banking, Biologics, Small Molecules, Others
GMP Storage Market by End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Research & Academic Institutes
GMP Storage Market by Region: North America GMP Storage Market, Latin America GMP Storage Market, Europe GMP Storage Market, South Asia GMP Storage Market, East Asia GMP Storage Market, Oceania GMP Storage Market, The Middle East & Africa GMP Storage Market
Related Reports:
Lysosomal Storage Diseases Therapeutics Market : https://www.persistencemarketresearch.com/market-research/lysosomal-storage-diseases-market.asp
Autologous Matrix-Induced Chondrogenesis (AMIC) Market : https://www.persistencemarketresearch.com/market-research/autologous-matrixinduced-chondrogenesis-market.asp
Contact Us:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research's Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GMP Storage Market is expected to witness a significant volume CAGR of approximately 5.6% through 2032 here
News-ID: 2874337 • Views: …
More Releases from Persistence Market Research
Antimicrobial Additives Market Expected to Grow at 7.8% CAGR Between 2025 and 20 …
The antimicrobial additives market has evolved into a critical segment within the global specialty chemicals and materials landscape, driven by the growing need to control microbial contamination across healthcare, food packaging, construction, automotive, and consumer goods industries. Antimicrobial additives are incorporated into materials such as plastics, coatings, textiles, and papers to inhibit the growth of bacteria, fungi, and other microorganisms throughout a product's lifecycle. Their role has expanded beyond basic…
Smart Manufacturing Market Valued at US$394.4 Billion in 2025, Expected to Reach …
The smart manufacturing market represents a fundamental transformation in how goods are designed, produced, monitored, and delivered across global industries. It combines advanced digital technologies such as industrial Internet of Things (IIoT), artificial intelligence (AI), machine learning, robotics, cloud computing, digital twins, and advanced analytics to create highly connected, automated, and intelligent production environments. Unlike traditional manufacturing, smart manufacturing enables real-time decision-making, predictive maintenance, adaptive production planning, and end-to-end visibility…
Oligonucleotide Synthesis Market Forecast Signals Strong Expansion During 2025-2 …
The oligonucleotide synthesis market has evolved from a niche research-support function into a strategic pillar of modern biotechnology and pharmaceutical development. Oligonucleotides-short, synthetically produced DNA or RNA sequences-are indispensable in applications ranging from basic genetic research and molecular diagnostics to advanced therapeutics such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and RNA- and DNA-based vaccines. As precision medicine continues to reshape healthcare, the ability to reliably synthesize high-quality, customized…
Genome Editing Market Demand Surges Across Biotechnology and Pharmaceutical Sect …
The genome editing market has emerged as one of the most transformative segments within modern biotechnology, reshaping how scientists, clinicians, and agricultural innovators approach genetic modification. Genome editing refers to a suite of technologies that allow precise alterations to DNA within living organisms, enabling the correction of genetic defects, enhancement of desirable traits, and development of advanced therapeutic solutions. Over the past decade, breakthroughs such as CRISPR/Cas9, base editing, and…
More Releases for GMP
Creative Peptides Released GMP Synthesis Service
Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more…
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm (diapharm.com) is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd (www.neptunepharma.com) in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (www.trident-50.com), is manufactured onsite under EU…
ECA Foundation releases free GMP WebApp
The ECA Foundation has been providing advanced training and information services in the pharmaceutical industry and especially with regard to pharmaceutical Quality Assurance and GMP compliance for more than 10 years. Now the organisation took advantage of its extensive experience to develop a further free of charge service – the new GMP WebApp.
This new GMP WebApp runs on all smartphones and tablet PCs (Apple and Android platforms) and allows users…
GMP Friction Products Awarded ISO 9001:2008
Internationally Recognized Certification Measures Consistency in Process, Procedure and Quality Performance in Manufacture of Friction Materials
AKRON, OH (March 23, 2011) -- GMP Friction Products, a world leader manufacturing powdered metal friction products for clutch plates and brake pads, recently received certification for ISO 9001:2008.
“ISO 9001:2008 signifies we have taken the extra measure of documenting the policies and standards to ensure consistent compliance with our manufacturing processes,” said Jerry Lynch,…
GMP MANUAL Volume 2 - Validation Procedures by Maas & Peither AG – GMP Publish …
GMP Publishing is launching its new GMP MANUAL Volume 2 – Validation Procedures.
The compendium on validation procedures was written by Dr. Doris Borchert, Dr. Peter Bosshard, Dr. Ralph Gomez, Dr. Michael Hiob, Dr. Christine Oechslein, Max Lazar, Ulrike Reuter, Michael Schulte, Uwe Schwarzat – all international experts and key opinion leaders. They share their detailed understanding of the various aspects of the validation process in clear and comprehensive style…
blue inspection body celebrates 50 GMP audits
Münster (Germany), 20 November 2009. Two years after founding the company and just 18 months after gaining the accreditation blue inspection body GmbH announced today the successful execution of its 50th GMP audit. Further audit trips to China, India, Israel and various European countries have been scheduled already, meaning that in the first quarter 2010 the 75th audit is targeted to be completed. Blue, as a privately organised inspection body,…
